February 24, 2005 A strong rally took biotech higher late on Thursday, regaining much of the territory lost in Tuesday’s big slide. The Centient Biotech 200 gained 1.21%, moving up 39 points to 3304.53. Among stocks in the news, Pfizer made another acquisition, buying Idun Pharma, a small, privately held biotech, Cephalon announced serious side-effects associated with off-label use of Gabitril, Anika Therapeutics gained 27% on good earnings, and four companies won James D. Watson Helix Awards for significant advancements during 2004: OSI Pharma, Biogen Idec, Medarex, and Genmab. We give details...
